500 related articles for article (PubMed ID: 33580957)
1. Clostridioides difficile phage biology and application.
Heuler J; Fortier LC; Sun X
FEMS Microbiol Rev; 2021 Sep; 45(5):. PubMed ID: 33580957
[TBL] [Abstract][Full Text] [Related]
2. A Novel Bacteriophage with Broad Host Range against Clostridioides difficile Ribotype 078 Supports SlpA as the Likely Phage Receptor.
Whittle MJ; Bilverstone TW; van Esveld RJ; Lücke AC; Lister MM; Kuehne SA; Minton NP
Microbiol Spectr; 2022 Feb; 10(1):e0229521. PubMed ID: 35107319
[TBL] [Abstract][Full Text] [Related]
3. Diversity, Dynamics and Therapeutic Application of
Nale JY; Thanki AM; Rashid SJ; Shan J; Vinner GK; Dowah ASA; Cheng JKJ; Sicheritz-Pontén T; Clokie MRJ
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560776
[No Abstract] [Full Text] [Related]
4.
Selle K; Fletcher JR; Tuson H; Schmitt DS; McMillan L; Vridhambal GS; Rivera AJ; Montgomery SA; Fortier LC; Barrangou R; Theriot CM; Ousterout DG
mBio; 2020 Mar; 11(2):. PubMed ID: 32156803
[No Abstract] [Full Text] [Related]
5. Phage therapy for
Fujimoto K; Uematsu S
Front Immunol; 2022; 13():1057892. PubMed ID: 36389774
[No Abstract] [Full Text] [Related]
6. Clostridioides difficile - phage relationship the RNA way.
Kreis V; Soutourina O
Curr Opin Microbiol; 2022 Apr; 66():1-10. PubMed ID: 34922145
[TBL] [Abstract][Full Text] [Related]
7. Frontiers in antibiotic alternatives for
Phanchana M; Harnvoravongchai P; Wongkuna S; Phetruen T; Phothichaisri W; Panturat S; Pipatthana M; Charoensutthivarakul S; Chankhamhaengdecha S; Janvilisri T
World J Gastroenterol; 2021 Nov; 27(42):7210-7232. PubMed ID: 34876784
[No Abstract] [Full Text] [Related]
8. Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo.
Nale JY; Spencer J; Hargreaves KR; Buckley AM; Trzepiński P; Douce GR; Clokie MR
Antimicrob Agents Chemother; 2016 Feb; 60(2):968-81. PubMed ID: 26643348
[TBL] [Abstract][Full Text] [Related]
9. Bacteriophage endolysins as a potential weapon to combat
Mondal SI; Draper LA; Ross RP; Hill C
Gut Microbes; 2020 Nov; 12(1):1813533. PubMed ID: 32985336
[No Abstract] [Full Text] [Related]
10. Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.
Collins DA; Riley TV
Lett Appl Microbiol; 2022 Sep; 75(3):526-536. PubMed ID: 35119124
[TBL] [Abstract][Full Text] [Related]
11. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
[TBL] [Abstract][Full Text] [Related]
12. Emerging applications of phage therapy and fecal virome transplantation for treatment of Clostridioides difficile infection: challenges and perspectives.
Raeisi H; Noori M; Azimirad M; Mohebbi SR; Asadzadeh Aghdaei H; Yadegar A; Zali MR
Gut Pathog; 2023 May; 15(1):21. PubMed ID: 37161478
[TBL] [Abstract][Full Text] [Related]
13. Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile Isolates.
Pensinger DA; Fisher AT; Dobrila HA; Van Treuren W; Gardner JO; Higginbottom SK; Carter MM; Schumann B; Bertozzi CR; Anikst V; Martin C; Robilotti EV; Chow JM; Buck RH; Tompkins LS; Sonnenburg JL; Hryckowian AJ
Infect Immun; 2023 Feb; 91(2):e0057022. PubMed ID: 36692308
[TBL] [Abstract][Full Text] [Related]
14. Host and microbial-derived metabolites for Clostridioides difficile infection: Contributions, mechanisms and potential applications.
Gao Y; Ma L; Su J
Microbiol Res; 2022 Oct; 263():127113. PubMed ID: 35841835
[TBL] [Abstract][Full Text] [Related]
15. Clostridioides difficile: Current overview and future perspectives.
Giles J; Roberts A
Adv Protein Chem Struct Biol; 2022; 129():215-245. PubMed ID: 35305720
[TBL] [Abstract][Full Text] [Related]
16. Identification of an anti-CRISPR protein that inhibits the CRISPR-Cas type I-B system in
Muzyukina P; Shkaruta A; Guzman NM; Andreani J; Borges AL; Bondy-Denomy J; Maikova A; Semenova E; Severinov K; Soutourina O
mSphere; 2023 Dec; 8(6):e0040123. PubMed ID: 38009936
[No Abstract] [Full Text] [Related]
17. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
[TBL] [Abstract][Full Text] [Related]
18. Pathogenicity and virulence of
Buddle JE; Fagan RP
Virulence; 2023 Dec; 14(1):2150452. PubMed ID: 36419222
[No Abstract] [Full Text] [Related]
19. Bacteriophages Contribute to Shaping
Fortier LC
Front Microbiol; 2018; 9():2033. PubMed ID: 30233520
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota in burned patients with Clostridioides difficile infection.
Shoaei P; Shojaei H; Siadat SD; Moshiri A; Vakili B; Yadegari S; Ataei B; Khorvash F
Burns; 2022 Aug; 48(5):1120-1129. PubMed ID: 34924229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
